160 related articles for article (PubMed ID: 31538194)
21. MRI surveillance of cancer cell fate in a brain metastasis model after early radiotherapy.
Murrell DH; Zarghami N; Jensen MD; Dickson F; Chambers AF; Wong E; Foster PJ
Magn Reson Med; 2017 Oct; 78(4):1506-1512. PubMed ID: 27851873
[TBL] [Abstract][Full Text] [Related]
22.
Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
[TBL] [Abstract][Full Text] [Related]
23.
Poty S; Mandleywala K; O'Neill E; Knight JC; Cornelissen B; Lewis JS
Theranostics; 2020; 10(13):5802-5814. PubMed ID: 32483420
[No Abstract] [Full Text] [Related]
24. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
25. Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis.
Zhang Q; Chen J; Yu X; Cai G; Yang Z; Cao L; Hu C; Guo X; Sun J; Chen J
Breast Cancer; 2016 Sep; 23(5):732-9. PubMed ID: 26267412
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
[TBL] [Abstract][Full Text] [Related]
27. Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-Hydroxyflavanone.
Singhal J; Singhal P; Horne D; Salgia R; Awasthi S; Singhal SS
Cancer Lett; 2018 Dec; 438():144-153. PubMed ID: 30223070
[TBL] [Abstract][Full Text] [Related]
28. Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.
Song HT; Jordan EK; Lewis BK; Liu W; Ganjei J; Klaunberg B; Despres D; Palmieri D; Frank JA
J Transl Med; 2009 Oct; 7():88. PubMed ID: 19840404
[TBL] [Abstract][Full Text] [Related]
29. Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model.
Gupta P; Adkins C; Lockman P; Srivastava SK
PLoS One; 2013; 8(6):e67278. PubMed ID: 23826254
[TBL] [Abstract][Full Text] [Related]
30. Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes.
Gauberti M; Montagne A; Marcos-Contreras OA; Le Béhot A; Maubert E; Vivien D
Stroke; 2013 Jul; 44(7):1988-96. PubMed ID: 23743972
[TBL] [Abstract][Full Text] [Related]
31. Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study.
Nounou MI; Adkins CE; Rubinchik E; Terrell-Hall TB; Afroz M; Vitalis T; Gabathuler R; Tian MM; Lockman PR
Pharm Res; 2016 Dec; 33(12):2930-2942. PubMed ID: 27528392
[TBL] [Abstract][Full Text] [Related]
32. Molecular MRI enables early and sensitive detection of brain metastases.
Serres S; Soto MS; Hamilton A; McAteer MA; Carbonell WS; Robson MD; Ansorge O; Khrapitchev A; Bristow C; Balathasan L; Weissensteiner T; Anthony DC; Choudhury RP; Muschel RJ; Sibson NR
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6674-9. PubMed ID: 22451897
[TBL] [Abstract][Full Text] [Related]
33. Outcome and prognostic value of treatment for brain metastases and the primary tumor in patients with breast cancer brain metastases.
Wang Y; Ji Z; Lin FH; Wang XH; Wan-Ming H; He ZQ; Duan H; Guo CC; Zhang XH; Mou YG
Clin Neurol Neurosurg; 2018 Jul; 170():43-46. PubMed ID: 29727800
[TBL] [Abstract][Full Text] [Related]
34. Skeletal 212Pb retention following 224Ra injection: extrapolation of animal data to adult humans.
Schlenker RA
Health Phys; 1988 Apr; 54(4):383-96. PubMed ID: 3350659
[TBL] [Abstract][Full Text] [Related]
35. Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.
Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
PLoS One; 2016; 11(7):e0159904. PubMed ID: 27467592
[TBL] [Abstract][Full Text] [Related]
36. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
[TBL] [Abstract][Full Text] [Related]
37. Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model.
Wu YJ; Muldoon LL; Gahramanov S; Kraemer DF; Marshall DJ; Neuwelt EA
J Neurooncol; 2012 Oct; 110(1):27-36. PubMed ID: 22842979
[TBL] [Abstract][Full Text] [Related]
38. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
[TBL] [Abstract][Full Text] [Related]
39. Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice.
Jacobsen K; Kravitz J; Kincade PW; Osmond DG
Blood; 1996 Jan; 87(1):73-82. PubMed ID: 8547679
[TBL] [Abstract][Full Text] [Related]
40. Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis.
Layer JP; Hamed M; Potthoff AL; Dejonckheere CS; Layer K; Sarria GR; Scafa D; Koch D; Köksal M; Kugel F; Grimmer M; Holz JA; Zeyen T; Friker LL; Borger V; Schmeel FC; Weller J; Hölzel M; Schäfer N; Garbe S; Forstbauer H; Giordano FA; Herrlinger U; Vatter H; Schneider M; Schmeel LC
J Neurooncol; 2023 Aug; 164(1):107-116. PubMed ID: 37477822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
